NFTRH+; Tax Loss/Jan. Effect Examples

Understand that these are just two stocks (without highly liquid volumes) that I am interested in for my own reasons and there is a market full of others out there.  So these are not recommendations but rather, examples of charts that I look for at year end.

OncoMed (OMED) is held in the IRA as a sort of lottery ticket speculation.  I bought it a few weeks ago at just above 19, rode it up and am riding it back down currently.  While I sold several other items on the market bounce, I decided to keep this one because little has changed since it was driven to the 40’s last year by a news release that I considered fundamentally valid (for a very speculative specialty pharma/biotech stock that is).

Continue reading “NFTRH+; Tax Loss/Jan. Effect Examples”